Atlas Trials

A Single Dose BE Study of X-396 in Healthy Volunteers Under Fasted Conditions

Clinical trial NCT05665283 · COMPLETED

Trial details

NCT number
NCT05665283
Sponsor
Xcovery Holdings, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalency
Start date
2022-11-29
Primary completion
2023-01-18
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.